Skip to main content
Fig. 6 | Breast Cancer Research

Fig. 6

From: The prognostic value of a combined immune score in tumor and immune cells assessed by immunohistochemistry in triple-negative breast cancer

Fig. 6

The progression-free survival (PFS) and overall survival (OS) of tumor cells combined immune score (TCIS) groups, according to the combination of mRNA expression levels of PD-L1, B7-H2, and OX40 retrieved from TCGA database. A PFS in breast cancer, B OS in breast cancer, C PFS in TNBC, and D OS in TNBC. TCGA, The Cancer Genome Atlas; BRCA, breast cancer; TNBC, triple-negative breast cancer

Back to article page